MICHELLE NAURECKI: Open Payments
NPI 1841718087 · WAUCONDA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,465 in 56 payments from 14 companies in 2025. Trend: 2023 $226 · 2024 $564 · 2025 $1,465
Food & beverage: $1,465
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $303 |
| Abbott Laboratories | 2 | $192 |
| ABBVIE INC. | 20 | $183 |
| Novo Nordisk Inc | 7 | $182 |
| Teva Pharmaceuticals USA, Inc. | 3 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| Paratek Pharmaceuticals, Inc. | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Biogen, Inc. | 1 | $20 |
Products named: FREESTYLE LIBRE 3, ZEPBOUND, Ozempic, JARDIANCE, AUSTEDO XR, BREZTRI, MOUNJARO, QULIPTA.
Industry payments across IL — which companies pay providers there.
